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AbstrACt
Objective Describe research methods used in priority-
setting exercises for musculoskeletal conditions and 
synthesise the priorities identified.
Design Scoping review.
setting and population Studies that elicited the research 
priorities of patients/consumers, clinicians, researchers, 
policy-makers and/or funders for any musculoskeletal 
condition were included.
Methods and analysis We searched MEDLINE and 
EMBASE from inception to November 2017 and the James 
Lind Alliance top 10 priorities, Cochrane Priority Setting 
Methods Group, and Cochrane Musculoskeletal and Back 
Groups review priority lists. The reported methods and 
research topics/questions identified were extracted, and a 
descriptive synthesis conducted.
results Forty-nine articles fulfilled our inclusion criteria. 
Methodologies and stakeholders varied widely (26 
included a mix of clinicians, consumers and others, 16 
included only clinicians, 6 included only consumers or 
patients and in 1 participants were unclear). Only two 
(4%) reported any explicit inclusion criteria for priorities. 
We identified 294 broad research priorities from 37 
articles and 246 specific research questions from 17 
articles, although only four (24%) of the latter listed 
questions in an actionable format. Research priorities 
for osteoarthritis were identified most often (n=7), 
followed by rheumatoid arthritis (n=4), osteoporosis 
(n=4) and back pain (n=4). Nearly half of both broad and 
specific research priorities were focused on treatment 
interventions (n=116 and 111, respectively), while 
few were economic (n=8, 2.7% broad and n=1, 0.4% 
specific), implementation (n=6, 2% broad and n=4, 1.6% 
specific) or health services and systems research (n=15, 
5.1% broad and n=9, 3.7% specific) priorities.
Conclusions While many research priority-setting 
studies in the musculoskeletal field have been performed, 
methodological limitations and lack of actionable research 
questions limit their usefulness. Future studies should 
ensure they conform to good priority-setting practice 
to ensure that the generated priorities are of maximum 
value.
PrOsPErO registration number CRD42017059250.
bACkgrOunD 
Conditions, such as low back and neck pain, 
osteoarthritis, osteoporosis, rheumatoid 
arthritis, gout and ‘other’ musculoskeletal 
(MSK) conditions, have the fourth greatest 
impact on global health according to the 
Global Burden of Disease study.1 In Australia, 
MSK conditions account for over 10% of the 
total disease burden and make up almost a 
quarter (23%) of the total non-fatal burden.2 
They are among the top 30 most frequently 
managed chronic conditions in Australia,3 
and contribute notably to total health expen-
diture.4 In 2012, the total cost of arthritis and 
other MSK conditions in Australia was an 
estimated $5.5 billion, including both direct 
(treatment), and indirect (loss of produc-
tivity), costs.4 
A review of MSK trial funding by the Austra-
lian National Health and Medical Research 
Council (NHMRC) between 2009 and 2013 
identified that funding for this area was 
disproportionately low relative to its burden 
despite it being an acknowledged National 
Health Priority Area.5 It is therefore impera-
tive that the limited funding directed to MSK 
health focus on the most important research 
priorities in the field to ensure the highest 
health return on investment.6
strengths and limitations of this study
 ► Independent, duplicate screening and extraction 
were conducted to minimise bias.
 ► It is possible that some priority-setting exercises 
were not identified despite the use of a broad search 
strategy.
 ► All priority-setting exercises were conducted in 
high-income countries, and thus, their results may 
not be generalisable to middle-income or low-in-
come settings.
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There are many ways of approaching priority setting 
including using Delphi methods (iterative consulta-
tions with stakeholders), trend analysis and modelling 
(to predict future burdens), scenario discussion, matrix 
approaches (using quantifiable data to consider the 
potential effect), and discrete choice methods (to eval-
uate trade-offs).7 8 The James Lind Alliance, for example, 
advocates a mixture of literature reviews, Delphi surveys 
and workshops that involve a range of stakeholders in 
identifying and ranking the top 10 priorities in order of 
importance.9
The Australia and New Zealand Musculoskeletal 
(ANZMUSC) Clinical Trials Network was recently estab-
lished to optimise MSK health through high quality, 
collaborative clinical trials research and to build research 
capacity in this field.10 To ensure that we focus on the most 
important evidence and evidence-practice gaps that are 
of most relevance to patients, clinicians, consumers and 
policy-makers, we aim to establish our own list of research 
priorities. To inform this work, we performed a scoping 
review of previous priority-setting projects for MSK condi-
tions. Our aims were both to describe the methods used 
to establish research priorities, as well as to synthesise the 
priorities that have been identified previously. In partic-
ular, we were interested in whether or not any previous 
priority-setting projects had used a transparent method 
to order their set of priorities and whether any identi-
fied priorities would be of use in our own priority-setting 
process.
MEthODs
selection criteria
We included articles that reported on research prioriti-
sation for any type of MSK condition. We defined MSK 
conditions as any form of arthritis (eg, rheumatoid 
arthritis, osteoarthritis, gout), autoimmune rheumatic 
conditions (eg, systemic lupus erythematosus, SLE), 
regional specific or non-specific MSK conditions (eg, 
low back pain), fractures and osteoporosis. Articles were 
included if they directly identified research priorities or 
research gaps from stakeholders including clinicians, 
consumers and researchers, irrespective of whether 
they were highly refined research questions or broad/
more general research topics. There was no limitation 
on age or setting. Priority setting for pain in general or 
major trauma was excluded. We also excluded editorials, 
commentaries, narrative reviews, priorities considered as 
part of clinical guidelines and priorities relating solely to 
outcome measurement, for example, outcome measures 
in rheumatology initiatives.
search strategy
We searched Ovid MEDLINE and EMBASE since incep-
tion to 20 November 2017 unrestricted by language. The 
specific search terms are listed in online supplemen-
tary appendix 1. We also searched the reference lists of 
included articles to identify additional relevant studies, 
the websites of the James Lind Alliance (http://www. jla. 
nihr. ac. uk/), their priority-setting partnerships (http://
www. jla. nihr. ac. uk/ priority- setting- partnerships/) and 
their priorities list (http://www. jla. nihr. ac. uk/ top- 10- 
priorities/), the website of the Cochrane Priority Setting 
Methods Group (http:// methods. cochrane. org/ priori-
tysetting/ resources), and the Cochrane Musculoskeletal 
and Cochrane Back groups priority lists for reviews.
Data abstraction and synthesis
The title and abstracts of identified articles were inde-
pendently screened by random and different pairs of 
reviewers across the author group. The full texts of poten-
tially eligible articles were obtained and also screened by 
random and different pairs of reviewers across the author 
group. We attempted to contact the authors of any arti-
cles that we could not obtain by other means. Discordant 
decisions were resolved by discussion or a third reviewer 
(RVJ or RB), if necessary.
For all included articles, two independent reviewers 
(AMB or SC and another reviewer across the author group) 
extracted relevant data to a standard data extraction 
form (online supplementary appendix 2). It included 
the following information: setting, participants (clini-
cians, consumers, researchers, policy-makers, industry 
representatives, etc), MSK condition(s), method(s) used 
to develop research priorities), criteria for priorities (if 
used), method of priority weighting (if used), funding 
and the priority topics identified. Differences in data 
extraction between reviewers were resolved by discussion 
or by a third reviewer if necessary (RB or RVJ).
Priorities that were only research topics (eg, ‘rehabil-
itation strategies’),11 were classified as broad priorities, 
while those that were specific research questions (eg, 
‘what is the relevance and use of red flags in the manage-
ment of MSK conditions?’),12 were classified as specific 
priorities. Two independent reviewers (AMB and either 
RB, CM or JL) further categorised all identified research 
priorities into themes. These empirically derived themes 
were then condensed in number to 13 themes: epidemi-
ology and burden; aetiology and risk factors; screening, 
diagnosis and assessment; natural history, prognosis and 
outcome; prevention; treatment (including prediction 
of response and mechanisms/rationale for treatment); 
outcome measurement; economic evaluation; imple-
mentation; health services and systems; research capacity 
building; research methods; and patient/consumer 
perspectives (focus on the impact or well-being of the 
patient). They were also mapped to a specific condition 
if relevant. Discrepancies in categorisation were discussed 
and resolved by consensus. No formal assessment of the 
quality of the prioritisation exercises was performed.
Patient involvement
One consumer representative but no patients were 
involved in the development, conduct or analysis of this 
review.
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rEsults
search results
We retrieved 4185 non-duplicate citations from our 
searches including 20 from other sources (figure 1). 
Of these, 4044 citations were excluded after screening 
titles and abstracts. Of 141 potentially eligible articles, 
two could not be located in full text (despite attempts 
to contact the first author) and therefore could not be 
screened (‘awaiting assessment’),13 14 leaving 139 for 
full-text review. Of these, 90 were excluded. Reasons 
for exclusion are summarised in figure 1 and detailed 
in online supplementary appendix 3). These included 
non-research articles, guidelines and articles that did not 
specify a list of research priorities.
Included studies
Conditions
Forty-nine articles fulfilled our inclusion criteria.11 12 15–61 
Most articles (n=29, 59%) were published in the last 10 
years.11 12 16–19 22–25 27–35 37–39 44 46 49–52 54 Twenty-two (45%) 
made priority recommendations for MSK conditions 
broadly or recommendations across a range of condi-
tions.12 15–30 55–58 61 For single conditions, research priorities 
for osteoarthritis were identified most often (n=7),11 31–36 
followed by rheumatoid arthritis (n=4),38 41–43 osteopo-
rosis (n=4)37 39 40 44 and back pain (n=4).45 46 48 53 Two 
studies identified priorities for orthopaedic surgery52 60 
and foot and ankle conditions not otherwise classified 
by a disease.47 59 Single studies identified priorities for 
gout,50 systemic sclerosis,51 surgery for common shoulder 
conditions49 and juvenile-onset SLE.54
Location and approach
The characteristics of the priority-setting processes 
in the included articles are summarised in table 1. 
One-third (n=14, 29%) included stakeholders from 
multiple continents while 33 (67%) were country 
specific. Almost half (n=23, 47%) used a combination 
of methods, including literature review, surveys and/or 
workshops.16 17 27 31–34 36 38–41 44 49 51–58 61 A combination of 
survey(s) and workshop(s) was the most common multi-
modal approach, while surveys or focus groups were 
common in unimodal approaches. Of the 11 (22%), 
priority-setting exercises that were informed by a system-
atic review,16 27 31–33 36 40 51 52 54–58 61 only one explicitly 
reported their search terms.36
Priority criteria, synthesis, implementation and evaluation
Only 2 priority-setting exercises (4%) reported 
explicit criteria for what could be considered a 
priority,15 23 15 (31%) limited priorities to specific 
research areas (eg, non-pharmacological interven-
tions)17 19 20 24 26 30 33 34 38 40 41 43 44 52 54 and 5 (10%) asked 
participants to rank preidentified priorities (although 
allowed them to suggest additional items).27 32 36 47 58 
The majority of articles broadly described how iden-
tified priorities were refined (n=32, 65%),12 15–17 19 20 
22–28 31 32 34–36 39 40 43–46 48 49 52–54 57 59 60 12 of which (24%) 
included a thematic analysis.12 16 20 23–25 28 35 36 39 44 54 
While most priority-setting exercises resulted in a 
ranked list of priorities, only two articles described 
priority weighting (by giving participants’ top three 
preferences across all categories double weighting,44 
or by allocating 100 points across their choices).59 
Figure 1 Article extraction flow chart.
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Only four groups or organisations updated or repeated 
their priority-setting exercise (The National Asso-
ciation of Orthopaedic Nurses,26 60 The Chartered 
Society of Physiotherapy14 23 The International Forum 
for Primary Care Research on Low Back Pain)46 53 and 
the Research Council of the American Orthopaedic 
Foot and Ankle Society.47 59 Another group assessed 
the progress related to chiropractic research prior-
ities but did not generate new priorities.62 63 Eleven 
studies (22%) outlined a strategy for implementing 
their priorities,22 24 31 44 49 52 55–58 61 (most of which were 
published since 2011)22 24 31 44 49 and one group (5%) 
reported that they had commenced a clinical trial to 
investigate one of the priorities identified.43
Participants
Sixteen priority-setting studies only included clini-
cians,11 15 26 33 42 43 46 48 52 55–61 six only included consumers 
or patients18 22 27 44 50 54 and in one the participants involved 
were unclear.37 Almost two-thirds of the studies (n=26, 53%) 
included a mix of clinicians, consumers and/or a range 
of others (eg, from industry, government and research 
backgrounds).12 16 17 19–21 23–25 28–32 34–36 38–41 45 47 49 51 53 Of 
the priority-setting exercises published since 2011 (n=23), 
less than half (n=11, 48%) include a range of stake-
holders.11 17 22 27 33 37 39 44 46 50 51 54 Two studies compared 
research priorities of different stakeholders.19 36 The 
majority of studies clearly explained the level of stake-
holder involvement (n=28, 57%), and of those that 
included clinicians, 33% (n=14) selected specific individ-
uals to panels or workshops.15 19 28–33 35 36 38 39 45 48
Funding
Most studies reported their funding source (n=31, 63%). 
Only two reported that no funding was received,46 50 while 
the remainder received funding from either professional 
associations,12 17 24 26 42 43 52 60 hospitals/institutes,28 32 36 
government,20 35 55–58 61 consumer groups22 40 or multiple 
sources.11 27 39 41 44 45 49
themes of identified research priorities
Thirty-seven articles identified 294 research priorities that 
were presented as broad topics or statements such as ‘biolog-
ical perspective’ or ‘economic evaluations’ to indicate a 
general research area that was considered a priority (table 2 
and online supplementary appendix 4). The median (IQR) 
number of broad topics identified per article was 7 (4–10). 
The most common theme they fell under was treatment 
(n=116, 39%), followed by patient/consumer perspec-
tives (n=41, 14%). Few of these broad topics identified as 
research priorities were for economic evaluations (n=8, 
3%),17 19 37 45 47 54 57 58 or screening, diagnosis and assessment 
(n=3, 1%).18 29 44 Thirteen of these broad topics were for 
specific foot conditions that required research and were not 
included in the thematic analysis because they could have 
been included in all themes.47 59
Seventeen (38%) articles identified 246 priorities 
in the form of specific research questions (table 2 
Table 1 Methods, specific characteristics of the priority-
setting approach, participants and funding of the included 
studies (n=49)
N (%)
Method/s used to identify priorities
  Combination of methods* 23 (46.9)
  Consensus (only)† 22 (44.9)
  Survey (only) 4 (8.2)
Specific characteristics of the priority-setting 
approach
  Predefined explicit criteria for what 
constitutes a priority
2 (4.1)
  Priorities limited to a specific area 15 (30.6)
  Priorities pregenerated (not produced by 
stakeholders)
5 (10.2)
  Methods for refining research priorities 
reported
32 (65.3)
  Ranking of some or all priorities 34 (69.4)
  Weighting by an explicit method 2 (4.1)
  Update or reassessment of an earlier 
priority-setting activity
5 (10.2)
  Explicit strategy to implement priorities 
reported
11 (22.4)
Participants
  Participants from ≥2 continents 14 (28.6)
  UK 12 (24.5)
  USA and/or Canada 19 (38.8)
  Europe 2 (4.1)
  Australia 2 (4.1)
  Total no of participants reported (range 
9–1396)
35 (71.4)
  Method for identifying participants 
reported
23 (46.9)
  Level of stakeholder involvement clear 28 (57.1)
  Clinicians (only) 42 (85.7)/(16 (32.7))
  Consumers or patients (only) 19 (38.8)/(6 (12.2))
  Range of stakeholders‡ 26 (53.1)
  Participants unclear 1 (2)
Funding
  Not explicitly reported 18 (36.7)
  Multiple funders 7 (14.3)
  Professional association§ 8 (16.3)
  Hospital/institute 3 (6.1)
  Government 8 (16.3)
  Consumer organisation 2 (4.1)
  Industry 1 (2)
  Not funded 2 (4.1)
*Studies included multiple methods (eg, survey and workshop).
†Consensus methods could have included workshops, group 
discussion, expert panels, nominal group techniques, focus groups, 
Delphi studies.
‡Other stakeholders included government, industry, researchers, 
educators, managers, administrators and funding agencies.
§Professional associations included orthopaedic nurses and 
trauma, rheumatology, physiotherapy and chiropractic groups.
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and online supplementary appendix 5), with a median 
of 10 (IQR 5–17) priorities per article. Most of these 
specific research questions were for treatment (n=111, 
45%) and only nine priorities (4%) from four priori-
ty-setting exercises were related to health services and 
systems research.32 35 46 57 Most specific research questions 
identified as priorities were not reported in an actionable 
form. Only three (18%) articles reported all31 49 or some32 
priorities in the form of Patient Intervention Control 
Outcomes (PICO)-formatted questions, and one article 
listed specific Cochrane review topics.34
Figures 2 and 3 show the number of broad research 
topics and specific research questions identified as prior-
ities for each condition. The majority of both broad 
research topics and specific research questions identified 
as priorities were focused on treatments (n=116, 39% and 
n=111, 45%, respectively), although no treatment prior-
ities were identified for SLE.54 The majority of broad 
Figure 2 Matrix of broad research topics identified as priorities in musculoskeletal (MSK) conditions. Size of the circles 
indicates the number (N) of priorities.
Table 2 Summary of broad (n=37 articles, 294 priorities) and specific (n=17 articles, 246 priorities) research priorities
Category
Broad topics Specific questions
N (%) No of articles
No of 
conditions N (%)
No of 
articles
No of 
conditions
Epidemiology and burden 12 (4.1) 9 5 6 (2.4) 2 2
Aetiology and risk factors 19 (6.5) 13 6 18 (7.3) 5 4
Screening, diagnosis and assessment 3 (1.0) 3 2 14 (5.7) 5 3
Prevention 5 (1.7) 5 3 4 (1.6) 4 4
Treatment 116 (39.5) 25 8 111 (45.1) 16 8
Natural history, prognosis and 
outcome
22 (7.5) 11 5 18 (7.3) 8 7
Outcome measurement 9 (3.1) 8 4 18 (7.3) 5 3
Economic evaluation 8 (2.7) 8 5 1 (0.4) 1 1
Implementation 6 (2.0) 5 2 4 (1.6) 4 4
Health services and systems 15 (5.1) 7 5 9 (3.7) 4 3
Research capacity building 28 (9.5) 9 2 6 (2.4) 2 2
Research methods 11 (4.1) 8 3 2 (0.8) 2 1
Patient/consumer perspective 41 (13.9) 13 5 21 (8.5) 5 2
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research topics listed as priorities (see figure 2) were from 
priority-setting exercises that considered MSK condi-
tions broadly, or across several conditions (n=170, 58%), 
with ≥2 priority topics listed for each theme. Despite only 
being considered in three priority-setting exercises,22 37 39 
the 24 broad research topics identified as priorities for 
osteoporosis were spread across nine themes. Only specific 
research questions were identified as priorities in priori-
ty-setting exercises for shoulder and orthopaedic surgery 
(see figure 3). Specific research questions from two back 
pain priority-setting exercises45 46 were identified as prior-
ities across 11 research themes, while the one exercise for 
osteoporosis40 only identified specific questions as priori-
ties across the themes of prevention and treatment.
DIsCussIOn
We identified 49 articles published up until November 
2017 that reported on some form of research prioritisa-
tion in MSK conditions. These initiatives identified 294 
priorities listed as broad research topics and 246 prior-
ities listed as specific research questions. Most priori-
ties concerned treatment of MSK conditions broadly or 
multiple conditions. Relatively few articles considered 
implementation or health services and systems research, 
and only three priority-setting exercises translated some 
or all their priorities into specific, actionable well-con-
structed research questions (eg, in PICO format).
There is no universally accepted gold standard for 
priority-setting exercises, however, critical aspects include 
clearly defining the context, use of a detailed structured 
approach to guide the process, explicit criteria for what 
constitutes a priority, inclusiveness of all stakeholders and 
ensuring their representativeness, being well informed, 
transparency and plans for both implementation and 
evaluation.64 65 The broad results of this study are similar 
to systematic reviews of priority-setting projects in other 
fields,66–69 in that no study clearly considered all the crit-
ical aspects necessary to make a priority-setting exercise of 
maximum benefit. Many of the priority-setting exercises 
identified in this review involved a range of stakeholders. 
Engagement of all relevant stakeholders is recognised as 
an essential component of priority-setting exercises, since 
research that is relevant to all parties is more likely to be 
adopted in practice.70 71 While nearly 50% of the priori-
ty-setting exercises in our review reported some level of 
consumer or patient engagement, similar to other system-
atic reviews,70 the manner and extent of engagement 
varied.
As noted in other fields,67 68 priority-setting exercises 
that only involved consumers, such as the one for SLE,54 
tended to list broader priorities relating to quality of life 
and support, consistent with systematic review evidence 
in this area.72 In contrast, clinician-only priorities, such 
as those identified for orthopaedic surgery,52 were gener-
ally more specific and focused on diagnostic or treatment 
aspects. Most also generally lacked sufficient method-
ological detail to enable replication including an explicit 
description of what would be considered a priority. Finally, 
only a minority were informed by a literature review, 
which while not relevant for all situations, is important 
in verifying that priorities are truly based on uncertain-
ties or need.9 While we did not note any improvement 
Figure 3 Matrix of specific research questions identified as priorities in musculoskeletal (MSK) conditions. Size of the circles 
indicates the number (N) of priorities.
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in priority-setting methods or stakeholder involvement 
in our review since publication of a checklist identifying 
the nine common themes of good priority-setting prac-
tice in 2010,65 this may require more time. By contrast, 
systematic reviews of priority setting in other fields have 
noted an increased breadth of stakeholder involvement 
over time.67 68 Such lack of detail severely limited the 
utility of the priorities identified as a starting point for 
ANZMUSC’s own priority setting, and highlighted the 
need to be inclusive and comprehensive in conducting 
and reporting our own priority-setting exercises.
Disease burden is often a major consideration in iden-
tifying research priorities,65 yet, the priorities that were 
identified in the 49 included articles do not reflect the 
relative burden of different MSK conditions. Back pain 
is the leading cause of disability globally,73 but only three 
priority-setting exercises focused on generating priorities 
specifically for back pain. Similarly, neck pain is currently 
the sixth leading cause of global disability,73 but it was 
not considered by any group. In contrast, osteoarthritis, 
which is currently the 12th leading cause of disability glob-
ally,73 was considered in eight articles. A similar discord 
between burden and research was noted in a scoping 
review which found that in Australia, more clinical trials 
were being funded and conducted for osteoarthritis than 
back and neck pain combined.5 The discord between 
burden of disease and condition-specific research prior-
itisation likely reflects a lack of recognition of disease 
burden and/or other drivers of priority setting.
It was also noteworthy that very few priority-setting exer-
cises generated priorities related to economic evaluation, 
implementation and health services and systems, despite 
the ability for improvements in service delivery models to 
reduce the burden on the healthcare system and conse-
quently improve patient care.74 A distinct lack of priorities 
in health services and economic research relative to treat-
ment and prevention priorities was also noted in a review 
of research priorities for kidney disease.67 This may be the 
result of a lack of health service providers, funders and 
policy-makers involvement with priority-setting exercises.
It is difficult to assess the extent to which the priorities 
identified in these articles have informed current trials or 
research funding, or the extent to which they have been 
adopted into the health services field. Only a limited 
number of groups have reviewed their priority list, and 
none have performed a rigorous evaluation, therefore, 
the utility of these efforts is unknown. For example, 
while trials investigating self-management interventions 
and implementation trials were identified as research 
priorities by several groups, a scoping review looking at 
what types of MSK clinical trials had been funded by the 
Australian government from 2009 to 2013 found that 
most trials were focused on investigating the value of 
physical therapy and drug interventions.5
This systematic review has a number of strengths and 
limitations. The broad search strategy helped ensure 
that no conditions were excluded. Also independent 
screening, assessment and data extraction by two authors 
ensured that data were collected in a manner that mini-
mised bias. Although we attempted to identify all relevant 
MSK condition priority-setting exercises, it is possible that 
some articles may have been missed, particularly those 
in the grey literature and in health policy documents. 
Further, the priority-setting exercises were all conducted 
in high-income countries and we did not identify any 
published priority-setting exercises specifically for low-in-
come or middle-income countries. Therefore, the identi-
fied research priorities may or may not be transferable to 
these settings.
In summary, only 3 out of the 49 articles we reviewed 
identified specific research priorities in a well-con-
structed format using replicable methods, and most prior-
ities focused on treatment. We recommend that future 
research priority-setting initiatives have a clear aim, use 
robust methods, include all relevant stakeholders and 
have a plan for implementation and evaluation. This will 
ensure greatest return on investment.
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